COLLABORATE El Meu Clínic . This link opens in a new tab.
Search
COLLABORATE El Meu Clínic . This link opens in a new tab.
Navigation thread
Ricard Cervera

Ricard Cervera

Autoimmune Diseases Head of Department

Research group

//orcid.org/0000-0001-6085-492X 0000-0001-6085-492X

About me

Ricard Cervera, MD, PhD, FRCP is Senior Consultant and Head at the Department of Autoimmune Diseases, Hospital Clínic de Barcelona, Director of the Research Group on Systemic Autoimmune Diseases at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) of Barcelona, Professor and Director of the UB-GSK Chair on Autoimmune Diseases, Coordinator of the Masters’ on Autoimmune Diseases and Academic Vice-Dean at the Faculty of Medicine and Health Sciences of the University of Barcelona (UB).

Featured publications

  • Anti Ro52 antibodies: One step further, but still not there yet

    Authors: Ríos-Garcés R, Cervera R .
    Reference: European Journal Of Internal Medicine 2021.

  • The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis

    Authors: Munguía-Realpozo P; Mendoza-Pinto C; García-Carrasco M; Berra-Romani R; Sierra-Benito C; Méndez-Martínez S; Cervera R.
    Reference: Autoimmunity Reviews 2021.

  • A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Authors: Soret P, Le Dantec C, Desvaux E, Foulquier N, Chassagnol B, Hubert S, Jamin C, Barturen G, Desachy G, Devauchelle-Pensec V, Boudjeniba C, Cornec D, Saraux A, Jousse-Joulin S, Barbarroja N, Rodríguez-Pintó I, De Langhe E, Beretta L, Chizzolini C, Kovács L, Witte T,, Bettacchioli E, Buttgereit A, Makowska Z, Lesche R, Borghi MO, Martin J, Courtade-Gaiani S, Xuereb L, Guedj M, Moingeon P, Alarcón-Riquelme ME, Laigle L, Pers JO PRECISESADS Clinical Consortium, PRECISESADS Flow Cytometry Consortium.
    Reference: Nature Communications 2021.

  • European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

    Authors: Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR .
    Reference: Annals Of The Rheumatic Diseases 2021.

  • Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Authors: Barturen G, Babaei S, Català-Moll F, Martínez-Bueno M, Makowska Z, Martorell-Marugán J, Carmona-Sáez P, Toro-Domínguez D, Carnero-Montoro E, Teruel M, Kerick M, Acosta-Herrera M, Le Lann L, Jamin C, Rodríguez-Ubreva J, García-Gómez A, Kageyama J, Buttgereit A, Hayat S, Mueller J, Lesche R, Hernandez-Fuentes M, Juarez M, Rowley T, White I, Marañón C, Gomes Anjos T, Varela N, Aguilar-Quesada R, Garrancho FJ, López-Berrio A, Rodriguez Maresca M, Navarro-Linares H, Almeida I, Azevedo N, Brandão M, Campar A, Faria R, Farinha F, Marinho A, Neves E, Tavares A, Vasconcelos C, Trombetta E, Montanelli G, Vigone B, Alvarez-Errico D, Li T, Thiagaran D, Blanco Alonso R, Corrales Martínez A, Genre F, López Mejías R, Gonzalez-Gay MA, Remuzgo S, Ubilla Garcia B, Cervera R, Espinosa G, Rodríguez-Pintó I, De Langhe E, Cremer J, Lories R, Belz D, Hunzelmann N, Baerlecken N, Kniesch K, Witte T, Lehner M, Stummvoll G, Zauner M, Aguirre-Zamorano MA, Barbarroja N, Castro-Villegas MC, Collantes-Estevez E, de Ramon E, Díaz Quintero I, Escudero-Contreras A, Fernández Roldán MC, Jiménez Gómez Y, Jiménez Moleón I, Lopez-Pedrera R, Ortega-Castro R, Ortego N, Raya E, Artusi C, Gerosa M, Meroni PL, Schioppo T, De Groof A, Ducreux J, Lauwerys B, Maudoux AL, Cornec D, Devauchelle-Pensec V, Jousse-Joulin S, Jouve PE, Rouvière B, Saraux A, Simon Q, Alvarez M, Chizzolini C, Dufour A, Wynar D, Balog A, Bocskai M, Deák M, Dulic S, Kádár G, Kovács L, Cheng Q, Gerl V, Hiepe F, Khodadadi L, Thiel S, de Rinaldis E, Rao S, Benschop RJ, Chamberlain C, Dow ER, Ioannou Y, Laigle L, Marovac J, Wojcik J, Renaudineau Y, Borghi MO, Frostegård J, Martín J, Beretta L, Ballestar E, McDonald F, Pers JO, Alarcón-Riquelme ME .
    Reference: Arthritis & Rheumatology 2021.

  • Understanding tubulointerstitial injury and repair mechanisms paves the way for renal outcome improvement in lupus nephritis

    Authors: Xipell M; Egan A; Lledó G; Villarreal JZ; Espinosa G; García-Herrera A; Cervera R; Jayne D; Quintana LF.
    Reference: Revista Colombiana De Reumatologia 2021.

  • Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines

    Authors: Pires Da Rosa G, Rodríguez-Pintó I, Cervera R, Espinosa G .
    Reference: Expert Review Of Hematology 2021.

  • Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature

    Authors: Moroni L, Righini P, Ramirez GA, Farina N, Mancuso G, Bozzolo E, Rodríguez-Pintó I, Cervera R, Nano G, Dagna L .
    Reference: Lupus 2021.

  • What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts

    Authors: Mucke J, Alarcon-Riquelme M, Andersen J, Aringer M, Bombardieri S, Brinks R, Cervera R, Chehab G, Cornet A, Costedoat-Chalumeau N, Czirják L, Doria A, Fischer-Betz R, Furie RA, Gatto M, Houssiau FA, Ines L, Liang MH, Morand E, Mosca M, Pego-Reigosa JM, Rúa-Figueroa I, Ruiz-Irastorza G, Terrier B, Voss A, Schneider M .
    Reference: Lupus Science And Medicine 2021.

Featured Projects

  • Desarrollo de un protocolo ELISPOT para la determinación y cuantificación de linfocitos B productores de anticuerpos anti-DNA de doble cadena en lupus eritematoso sistémico.

    Principal investigator: R. Cervera
    Funder: Hospital Clinic de Barcelona (Sede); Hospital Clinic de Barcelona ; Hospital Clinic de Barcelona (Participante)
    Duration: 01/06/2017 - 01/06/2018

  • Estudio de nuevos antígenos en esclerodermia

    Principal investigator: R. Cervera
    Funder: Hospital Clinic de Barcelona (Sede); Instituto de Salud Carlos III ; Hospital Clinic de Barcelona (Participante)
    Duration: 01/01/2017 - 01/12/2017

  • Síndromes linfoproliferativos asociados a inmunodeficiencia. Estudio clínico-patologico del papel de la replicación de los virus herpes oncogénicos y de la diferenciación plasmocelular. Identificación

    Principal investigator: Premi Fi de Residència de l'Hospital Clínic de Barcelona
    Duration: 01/01/2014

  • Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases Mechanisms for the Improvement of Drug Development and Therapy (PRECISESADS).

    Principal investigator: Ricard Cervera
    Code: 115565-3
    Duration: 01/01/2013 - 01/01/2018

  • Fenotipo pro y anticoagulante de las micropartículas circulantes en la patología trombótica arterial de las enfermedades autoinmunes.

    Principal investigator: Gerard Espinossa
    Duration: 01/01/2013 - 01/01/2014